1. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity. (November 2020) Authors: Gibson, Claire L.; Bassir Nia, Anahita; Spriggs, Sharron A.; DeFrancisco, Daniel; Swift, Amy; Perkel, Charles; Zhong, Xiaobo; Mazumdar, Madhu; Fernandez, Nicolas; Patel, Manishkumar; Kim-Schulze, Seunghee; Hurd, Yasmin L. Journal: Psychiatry research Issue: Volume 293(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis. (May 2023) Authors: Bassir Nia, Anahita; Gibson, Claire L; Spriggs, Sharron A; Jankowski, Samantha E; DeFrancisco, Daniel; Swift, Amy; Perkel, Charles; Galynker, Igor; Honrao, Chandrashekhar; Makriyannis, Alexandros; Hurd, Yasmin L Journal: Journal of psychopharmacology Issue: Volume 37:Number 5(2023) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗